GlaxoSmithKline PLC (NYSE:GSK)

40.19
Delayed Data
As of Aug 16
 +0.23 / +0.58%
Today’s Change
36.41
Today|||52-Week Range
42.47
+5.18%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Operating ActivitiesNet Income / Starting Line12.8B1.4B2.8B5.4B
 
 
 
 
 
Depreciation2.5B2.4B2.5B2.5B
 
 
 
 
 
Total Other Cash Flow-14.9B1.8B1.7B57.3M
 
 
 
 
 
Funds From Operations360.0M5.6B6.6B7.4B
 
 
 
 
 
Funds From/For Other Operating Expenses-2.6B-2.3B-1.4B-3.0B
 
 
 
 
 
Net Cash Flow - Operating Activities2.9B7.9B8.0B10.4B
 
 
 
 
 
 
InvestingIncrease In Investments-152.5M-144.0M-122.3M-425.4M
 
 
 
 
 
Decrease In Investments1.4B919.1M340.0M205.3M
 
 
 
 
 
Capital Expenditures-2.1B-2.1B-2.0B-1.8B
 
 
 
 
 
Fixed Asset Disposal15.7B251.7M752.1M286.7M
 
 
 
 
 
Net Assets From Acquisitions -5.4B0.00-154.5M-12.6B
 
 
 
 
Other Investing - Uses0.00-98.2M0.000.00
 
 
Other Investing - Sources360.0M380.8M61.8M341.4M
 
 
 
 
 
Net Cash Flow Investing9.0B-1.9B-2.0B-14.6B
 
 
 
 
 
 
FinancingShort Term Borrowings-3.6B129.2M-4.1B-2.6B
 
 
 
 
 
Long Term Borrowings0.000.002.9B13.5B
 
 
 
Long Term Debt Reduction-38.1M-24.2M-29.6M-37.3M
 
 
 
 
 
Net Proceeds Stock Sale111.3M119.8M72.1M98.7M
 
 
 
 
 
Common Preferred Redeemed-151.0M-99.6M-83.7M0.00
 
 
 
 
Common Dividends-5.9B-6.5B-5.0B-5.2B
 
 
 
 
 
Cash Dividends Paid - Total-5.9B-6.5B-5.0B-5.2B
 
 
 
 
 
Other Sources - Financing355.4M0.00119.8M--
 
 
 
Other Uses - Financing361.5M1.3B1.0B793.4M
 
 
 
 
 
Net Cash Flow - Financing-9.6B-7.7B-7.2B4.9B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-68.6M380.8M-128.8M10.7M
 
 
 
 
 
 
Net Change In Cash2.3B-1.6B-1.2B638.7M